|
SYNJ1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.50049999980695E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.86400000171616E-08 |
| Normal-vs-Stage2 |
3.018900E-03 |
| Normal-vs-Stage3 |
4.042000E-02 |
| Normal-vs-Stage4 |
4.240400E-01 |
| Stage1-vs-Stage2 |
6.883600E-01 |
| Stage1-vs-Stage3 |
2.817600E-01 |
| Stage1-vs-Stage4 |
6.514000E-01 |
| Stage2-vs-Stage3 |
6.229200E-01 |
| Stage2-vs-Stage4 |
7.856400E-01 |
| Stage3-vs-Stage4 |
9.750400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.2514000077083E-09 |
| Normal-vs-AfricanAmerican |
2.016000E-02 |
| Normal-vs-Asian |
3.750200E-01 |
| Caucasian-vs-AfricanAmerican |
5.045900E-02 |
| Caucasian-vs-Asian |
4.184800E-01 |
| AfricanAmerican-vs-Asian |
9.425400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.07010000252694E-08 |
| Normal-vs-Female |
8.718200E-03 |
| Male-vs-Female |
5.671500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.67250000000707E-05 |
| Normal-vs-Extreme_Weight |
7.64840002442924E-09 |
| Normal-vs-Obese |
5.696300E-02 |
| Normal-vs-Extreme_Obese |
9.93710000000148E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.415600E-01 |
| Normal_Weight-vs-Obese |
7.108400E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.021800E-01 |
| Extreme_Weight-vs-Obese |
7.680200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.167200E-01 |
| Obese-vs-Extreme_Obese |
7.124000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.319600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.922900E-03 |
| Normal-vs-Age(61-80Yrs) |
3.21490001287117E-09 |
| Normal-vs-Age(81-100Yrs) |
1.73079999998826E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.319200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.861600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.711600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.755600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.180500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.973400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.45500000054066E-07 |
| Normal-VS-Type2 PRCC |
2.54690000001112E-06 |
| Normal-VS-KIRP CIMP |
2.155600E-03 |
| Normal-VS-Unclassified PRCC |
2.009200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.555400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.735400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.509200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.153200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.204200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.660000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.84840000000608E-05 |
| Normal-vs-N1 |
5.794800E-01 |
| Normal-vs-N2 |
6.751300E-04 |
| N0-vs-N1 |
1.246180E-01 |
| N0-vs-N2 |
6.054600E-01 |
| N1-vs-N2 |
3.159600E-01 |
|
|
